» Articles » PMID: 39023828

Interrogating Erectile Dysfunction and Evaluating Novel Therapeutic Frontiers, with Emphasis on Stem Cell Strategies

Overview
Publisher Springer
Date 2024 Jul 18
PMID 39023828
Authors
Affiliations
Soon will be listed here.
Abstract

Male infertility arises from a complex interplay of factors affecting reproductive organs and various physiological pathways. Among these, erectile dysfunction (ED), a widespread global issue, plays a key role. While existing ED treatments address some aspects, achieving complete reversibility and avoiding side effects remains a challenge. In this context, stem cell therapy emerges as a promising, potentially transformative approach. Preliminary evidence from preclinical animal models and clinical trials highlights stem cell therapy's remarkable efficacy and effectiveness for ED. This novel strategy offers several advantages, including enhanced effectiveness and a reported absence of adverse side effects. This review delves into the causes of male infertility, with a particular focus on ED and its pathophysiology. We explore the current treatment landscape, highlighting therapy's existing strategies' limitations and stem cell therapy's unique potential. By examining relevant preclinical and clinical studies, we provide a comprehensive picture of this innovative approach and its promising future in restoring men's fertility and quality of life.

References
1.
Papadopoulou E, Varouktsi A, Lazaridis A, Boutari C, Doumas M . Erectile dysfunction in chronic kidney disease: From pathophysiology to management. World J Nephrol. 2015; 4(3):379-87. PMC: 4491929. DOI: 10.5527/wjn.v4.i3.379. View

2.
Ouyang B, Sun X, Han D, Chen S, Yao B, Gao Y . Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model. PLoS One. 2014; 9(3):e92825. PMC: 3963968. DOI: 10.1371/journal.pone.0092825. View

3.
Al Demour S, Adwan S, Jafar H, Rahmeh R, Alhawari H, Awidi A . Safety and Efficacy of 2 Intracavernous Injections of Allogeneic Wharton's Jelly-Derived Mesenchymal Stem Cells in Diabetic Patients with Erectile Dysfunction: Phase 1/2 Clinical Trial. Urol Int. 2021; 105(11-12):935-943. DOI: 10.1159/000517364. View

4.
Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F . Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010; 57(5):804-14. DOI: 10.1016/j.eururo.2010.02.020. View

5.
Najari B, Kashanian J . Erectile Dysfunction. JAMA. 2016; 316(17):1838. DOI: 10.1001/jama.2016.12284. View